1. Home
  2. DYAI vs NTIP Comparison

DYAI vs NTIP Comparison

Compare DYAI & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • NTIP
  • Stock Information
  • Founded
  • DYAI 1979
  • NTIP 1990
  • Country
  • DYAI United States
  • NTIP United States
  • Employees
  • DYAI N/A
  • NTIP N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • NTIP Multi-Sector Companies
  • Sector
  • DYAI Health Care
  • NTIP Miscellaneous
  • Exchange
  • DYAI Nasdaq
  • NTIP Nasdaq
  • Market Cap
  • DYAI 28.3M
  • NTIP 32.0M
  • IPO Year
  • DYAI 2004
  • NTIP 1998
  • Fundamental
  • Price
  • DYAI $1.18
  • NTIP $1.42
  • Analyst Decision
  • DYAI Strong Buy
  • NTIP
  • Analyst Count
  • DYAI 1
  • NTIP 0
  • Target Price
  • DYAI $6.00
  • NTIP N/A
  • AVG Volume (30 Days)
  • DYAI 199.4K
  • NTIP 36.9K
  • Earning Date
  • DYAI 08-12-2025
  • NTIP 08-11-2025
  • Dividend Yield
  • DYAI N/A
  • NTIP 7.04%
  • EPS Growth
  • DYAI N/A
  • NTIP N/A
  • EPS
  • DYAI N/A
  • NTIP N/A
  • Revenue
  • DYAI $3,554,344.00
  • NTIP $250,000.00
  • Revenue This Year
  • DYAI $22.56
  • NTIP N/A
  • Revenue Next Year
  • DYAI $30.95
  • NTIP N/A
  • P/E Ratio
  • DYAI N/A
  • NTIP N/A
  • Revenue Growth
  • DYAI 57.59
  • NTIP N/A
  • 52 Week Low
  • DYAI $0.91
  • NTIP $1.16
  • 52 Week High
  • DYAI $2.20
  • NTIP $1.78
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 71.14
  • NTIP 62.66
  • Support Level
  • DYAI $0.98
  • NTIP $1.40
  • Resistance Level
  • DYAI $1.20
  • NTIP $1.46
  • Average True Range (ATR)
  • DYAI 0.09
  • NTIP 0.06
  • MACD
  • DYAI 0.02
  • NTIP 0.01
  • Stochastic Oscillator
  • DYAI 65.28
  • NTIP 80.43

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: